ly3298176 tirzepatide Eli Lilly and phase results 2 on their dual GIP/GLP1 receptor agonist Tirzepatide CAS NO.2023788-19-2 LY3298176 99%HPLC
Pay in 4 interest-free payments of $5.99 Learn more
Shipping Estimate
USA
- USA
- CAN
- USA
- CAN
Ships within 48 hours · Estimated delivery Nov 16 - Nov 21





















